GNH USA

Europe — EMA

Iloprost (Iloprost Trometamol)

GNH USA supplies Iloprost (Iloprost), a prostacyclin analog for pulmonary arterial hypertension and digital ulcers in systemic sclerosis. Request a quote.

Iloprost Trometamol

Request sourcing

1
Pack/s

What is Iloprost Trometamol?

Iloprost, the active ingredient in Iloprost, is a prostacyclin analog presented as an intravenous solution for intravenous use. It is indicated for the management of pulmonary arterial hypertension and for the treatment of digital ulcers associated with systemic sclerosis in adult patients.

GNH USA supplies Iloprost as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, adhering to EU quality standards.

What is Iloprost Trometamol used for?

Iloprost is a prostacyclin analog used in the pulmonary vascular disease pathway.

Pulmonary arterial hypertension: improves exercise capacity and delays disease progression through pulmonary vasodilation. Digital ulcers associated with systemic sclerosis: promotes ulcer healing and reduces new ulcer formation by enhancing microcirculatory flow.

What are the side effects of Iloprost Trometamol?

Common Side Effects: - Headache: mild to moderate intensity during infusion. - Flushing: transient warmth and redness of the skin. - Nausea: occasional gastrointestinal upset. - Jaw pain: discomfort during chewing. - Hypotension: drop in blood pressure, especially with rapid infusion. - Infusion site pain: local discomfort at the catheter site.

Serious or Rare Side Effects: - Pulmonary edema: accumulation of fluid in the lungs. - Severe hypotension: marked blood pressure reduction requiring intervention. - Bleeding: increased risk due to antiplatelet effect. - Thrombocytopenia: low platelet count. - Arrhythmia: abnormal heart rhythm.

What precautions apply to Iloprost Trometamol?

Iloprost requires careful monitoring due to its potent vasodilatory effects.

Pregnancy: safety not established; avoid unless benefit outweighs risk. Renal impairment: monitor renal function and adjust infusion rate if needed. Hepatic impairment: use with caution; liver dysfunction may alter drug clearance. Concomitant vasodilators: risk of additive hypotension; adjust dosing accordingly. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Iloprost Trometamol interact with?

Iloprost may interact with several cardiovascular and anticoagulant agents.

Major Interactions (Avoid): - Epoprostenol: additive vasodilation may cause severe hypotension. - Sildenafil: combined use can lead to profound blood pressure drops. - Warfarin: enhanced antiplatelet effect increases bleeding risk.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: monitor blood pressure for additive effects. - Beta‑blockers: may blunt desired vasodilatory response. - Heparin or other anticoagulants: observe for signs of excessive bleeding.

Frequently asked questions

What conditions is Iloprost used to treat?+
Iloprost is approved for the treatment of pulmonary arterial hypertension, where it helps lower pulmonary arterial pressure and improve exercise capacity, and for digital ulcers associated with systemic sclerosis, where it promotes ulcer healing and reduces the formation of new ulcers by improving microcirculatory blood flow.
How does Iloprost work in the body?+
Iloprost acts as a selective agonist of the IP (prostacyclin) receptor on vascular smooth‑muscle cells. Activation raises cyclic AMP levels, causing vasodilation of pulmonary and systemic vessels and inhibiting platelet aggregation, which together improve blood flow and reduce vascular resistance.
What is the usual dose of Iloprost?+
The dosing regimen for Iloprost is individualized. A qualified prescriber determines the infusion rate, concentration, and duration based on the patient’s clinical condition, response, and tolerance. No fixed dose can be stated without a medical prescription.
Is Iloprost safe to use during pregnancy or breastfeeding?+
Safety data for Iloprost in pregnancy and lactation are limited. It is generally classified as contraindicated or to be used only if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.
How do I order Iloprost from GNH USA?+
To request Iloprost, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain logistics if needed), and required import documentation.
How does Iloprost compare with other prostacyclin therapies?+
Iloprost is a short‑acting prostacyclin analog administered intravenously, whereas agents like epoprostenol are also IV but have a shorter half‑life, and treprostinil can be given subcutaneously or inhaled. Iloprost offers flexible dosing and a favorable safety profile, but selection depends on patient preference, disease severity, and logistical considerations.
What are the storage and handling requirements for Iloprost?+
Iloprost must be stored refrigerated at 2‑8 °C. Keep the solution in its original container, protect it from light, and avoid freezing or shaking. If a temporary temperature excursion occurs, discard the product according to local regulations.
How is Iloprost administered to patients?+
Iloprost is given as an intravenous infusion, typically through a peripheral or central venous catheter. The infusion rate is set by the prescribing clinician and may be adjusted based on hemodynamic response and tolerability. Continuous monitoring of blood pressure and heart rate is recommended during administration.
What are the most serious risks associated with Iloprost therapy?+
The most serious adverse events include severe hypotension, pulmonary edema, significant bleeding due to its antiplatelet effect, thrombocytopenia, and life‑threatening arrhythmias. Patients should be monitored closely for these events, especially during the initial dosing period.
Who should not receive Iloprost?+
Iloprost is contraindicated in patients with known hypersensitivity to the drug or any prostacyclin analog, in those with uncontrolled severe hypotension, and in individuals with active bleeding disorders unless the benefits outweigh the risks. Caution is also advised for patients with severe hepatic or renal impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Iloprost Trometamol
Route
Intravenous Use
Manufacturer
Waymade B.V.
Origin
EU

Related products

Endoprost

Endoprost

Iloprost Trometamol

Italfarmaco S.P.A
EU
Ilomedin

Ilomedin

Iloprost Trometamol

Bayer Austria Gmbh
EU
Ilomedin

Ilomedin

Iloprost Trometamol

Bayer Ab
EU
Ilomedin

Ilomedin

Iloprost Trometamol

Bayer Oy
EU